A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)
This study is ongoing, but not recruiting participants.
Study NCT00824343
Information provided by Piramal Enterprises Limited
First Received on January 15, 2009.
Last Updated on January 23, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
